Skip to main content
. 2017 Sep 14;44(6):426–428. doi: 10.1159/000479237

Fig. 1.

Fig. 1

Platelet counts during and after treatment with PD-1 blockers. Nivolumab was administered on day 3 and 17 (blue arrows); pembrolizumab was given on day 31 and 50 (green arrows). Red arrows indicate corticosteroid applications. X-axis, time in days; y-axis, platelet count/µl blood.